-6.00% percent quarterly performance for Fate Therapeutics Inc (FATE) is not indicative of the underlying story
On Tuesday, Fate Therapeutics Inc (NASDAQ: FATE) opened lower -5.02% from the last session, before settling in for the closing price of $4.78. Price fluctuations